Home LiteratureArticle Details
PMID: 14625677 Published · ppublish English Journal Article Review

Long-range silencing and position effects at telomeres and centromeres: parallels and differences.

Cellular and molecular life sciences : CMLS ·Vol. 60 ·No. 11 ·2003-11-00 ·Pages 2303-18

Perrod S, Gasser SM

Abstract

Most of the human genome is compacted into heterochromatin, a form that encompasses multiple forms of inactive chromatin structure. Transcriptional silencing mechanisms in budding and fission yeasts have provided genetically tractable models for understanding heritably repressed chromatin. These silent domains are typically found in regions of repetitive DNA, that is, either adjacent to centromeres or telomeres or within the tandemly repeated ribosomal DNA array. Here we address the mechanisms of centromeric, telomeric and locus-specific gene silencing, comparing simple and complex animals with yeast. Some aspects are universally shared, such as histone-tail modifications, while others are unique to either centromeres or telomeres. These may reflect roles for heterochromatin in other chromosomal functions, like kinetochore attachment and DNA ends protection.

MeSH Terms
Animals Centromere/physiology Gene Silencing Heterochromatin/physiology Histone Deacetylases/physiology Humans Methylation RNA Interference Saccharomycetales/genetics Schizosaccharomyces/genetics Silent Information Regulator Proteins, Saccharomyces cerevisiae/physiology Sirtuin 2 Sirtuins/physiology Telomere/physiology
Chemicals
Heterochromatin Silent Information Regulator Proteins, Saccharomyces cerevisiae SIR2 protein, S cerevisiae Sirtuin 2 Sirtuins Histone Deacetylases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Perrod S
Department of Molecular Biology, University of Geneva, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland.
Gasser S M
References (43)
43 references, click to expand
  1. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Circulation. 2003 Dec 23;108(25):3084-91 PMID: 14638546
  2. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.
    Circulation. 2004 Jun 8;109(22):2807-16 PMID: 15184297
  3. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria.
    Circulation. 2004 Sep 21;110(12):1527-34 PMID: 15381658
  4. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.
    Circulation. 2009 Mar 3;119(8):1085-92 PMID: 19221222
  5. Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Anesthesiology. 2001 Jul;95(1):250-4 PMID: 11465564
  6. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.
    Nat Genet. 2004 Nov;36(11):1162-4 PMID: 15489853
  7. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
    Circulation. 2007 Apr 3;115(13):1710-20 PMID: 17372169
  8. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    J Cardiovasc Electrophysiol. 2004 Mar;15(3):300-6 PMID: 15030420
  9. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy.
    Am J Hum Genet. 2006 Dec;79(6):1081-8 PMID: 17186466
  10. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
    Circulation. 2006 Oct 24;114(17):1799-806 PMID: 17030684
  11. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias.
    Heart. 2001 Jan;85(1):53-6 PMID: 11119463
  12. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia.
    J Am Coll Cardiol. 2005 Mar 15;45(6):860-5 PMID: 15766820
  13. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.
    Br Heart J. 1994 Mar;71(3):215-8 PMID: 8142187
  14. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria.
    J Am Coll Cardiol. 2002 Oct 16;40(8):1445-50 PMID: 12392835
  15. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart Vessels. 2007 May;22(3):184-92 PMID: 17533523
  16. Does sports activity enhance the risk of sudden death in adolescents and young adults?
    J Am Coll Cardiol. 2003 Dec 3;42(11):1959-63 PMID: 14662259
  17. Familial occurrence of right ventricular dysplasia: a study involving nine families.
    J Am Coll Cardiol. 1988 Nov;12(5):1222-8 PMID: 3170963
  18. Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations.
    Br J Sports Med. 2010 Feb;44(2):148-54 PMID: 18603583
  19. [Guidelines for catheter ablation].
    Clin Res Cardiol. 2007 Nov;96(11):833-49 PMID: 17955158
  20. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators.
    Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):676-86 PMID: 17001205
  21. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
    Am J Hum Genet. 2008 Apr;82(4):809-21 PMID: 18313022
  22. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Circulation. 1992 Jul;86(1):29-37 PMID: 1617780
  23. [Guidelines for the implantation of defibrillators].
    Clin Res Cardiol. 2006 Dec;95(12):696-708 PMID: 17103126
  24. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.
    Circulation. 2004 Oct 19;110(16):2293-8 PMID: 15477406
  25. Genes causing inherited forms of cardiomyopathies. A current compendium.
    Herz. 2009 Mar;34(2):98-109 PMID: 19370325
  26. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies.
    Eur Heart J. 2006 Aug;27(15):1847-54 PMID: 16774985
  27. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.
    J Am Coll Cardiol. 1997 Nov 15;30(6):1512-20 PMID: 9362410
  28. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy.
    J Am Coll Cardiol. 2000 Dec;36(7):2226-33 PMID: 11127465
  29. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Eur Heart J. 2005 Jul;26(14 ):1422-45 PMID: 15923204
  30. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.
    Circulation. 1994 Feb;89(2):667-83 PMID: 8313555
  31. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    J Am Coll Cardiol. 2004 May 19;43(10):1843-52 PMID: 15145110
  32. [Guideline invasive electrophysiological diagnostics].
    Clin Res Cardiol. 2007 Sep;96(9):634-51 PMID: 17687504
  33. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
    Prog Cardiovasc Dis. 2008 Jan-Feb;50(4):282-93 PMID: 18156007
  34. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy.
    Int J Cardiol. 1999 Dec 1;71(3):243-50 PMID: 10636530
  35. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle.
    J Am Coll Cardiol. 2006 Dec 5;48(11):2277-84 PMID: 17161260
  36. [Arrhythmogenic right ventricular cardiomyopathy].
    Herz. 2005 Sep;30(6):565-70 PMID: 16170690
  37. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.
    N Engl J Med. 2009 Mar 12;360(11):1075-84 PMID: 19279339
  38. Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine.
    Hum Pathol. 2006 Jul;37(7):794-801 PMID: 16784977
  39. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia.
    J Cardiovasc Magn Reson. 2008 Jun 20;10:32 PMID: 18570661
  40. Right ventricular cardiomyopathy and sudden death in young people.
    N Engl J Med. 1988 Jan 21;318(3):129-33 PMID: 3336399
  41. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    J Am Coll Cardiol. 2007 Nov 6;50(19):1813-21 PMID: 17980246
  42. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.
    Heart. 2005 Sep;91(9):1167-72 PMID: 16103549
  43. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Circulation. 2004 Mar 30;109(12):1503-8 PMID: 15007002
Article Info
Journal
Cellular and molecular life sciences : CMLS
Abbr.
Cell Mol Life Sci
ISSN
1420-682X
Published
2003-11-00
Pages
2303-18
Language
English
Region
Switzerland
NLM ID
9705402
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com